Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction

Abstract

The article is devoted to issues of clinical diagnosis and treatment of patients with chronic cardiac failure and normal ejection fraction (CCF-NEF). Original clinical trials of felodipin efficacy designed to be maximally close to every-day clinical practice in Russia included hypertensive patients with CCF-NEF. The results of these trials bring about the conclusion that felodipin not only maintain blood pressure at the target level but also improves diastolic function of the myocardium.

Keywords

• arterial hypertension
• chronic cardiac failure
• preserved ejection fraction
• felodipin